In a previous study on pancreatic cancer, we reported that 125I seed implantation combined with gemcitabine improved the ratio of Bax/Bcl-2 in pancreatic cancer cells, yielding a clinically better anti-proliferation effect (15). Here, BCL2 is linked to familial pancreatic carcinoma.